Eikon Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | -79,655 | -64,924 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -41,790 | -63,258 |
Cash | 104,901 | 129,179 |
Basic Shares | 53,984 | 53,984 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Net Income | -324,248 | -243,814 | -241,997 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -235,257 | -219,602 | -219,361 |
Cash | 104,901 | 129,179 | 112,784 |
Basic Shares | 53,984 | 53,984 | 53,984 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$26.23 |
